FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W200907363> ?p ?o ?g. }

• W200907363 endingPage "3716" @default.
• W200907363 startingPage "3707" @default.
• W200907363 abstract "We determined the type and frequency of chromosomal aberrations in leukemic cells of 478 children diagnosed with acute myeloid leukemia and enrolled in the Pediatric Oncology Group study 8821. Of the 478 cases, 109 (22.8%) had normal karyotypes. Chromosomal abnormalities of 280 patients (58.6%) were classified into subgroups: 11q23 abnormalities (n = 88, 18.4%), t(8;21) (n = 56, 11.7%), t(15;17) (n = 55, 11.5%), inv(16)/t(16;16) (n = 28, 5.9%), trisomy 8 alone (n = 10, 2.1%), monosomy 7 (n = 9, 1.9%), non-Down-associated trisomy 21 alone (n = 7, 1.5%), and rare recurrent chromosomal translocations (n = 27, 5.6%). The remaining 89 patients (18.6%) had miscellaneous clonal abnormalities. Overall, 84.9% of the children achieved a complete remission; the 4-year event-free survival (EFS) estimate was 33.8% +/- 2.4%. Remission rates were significantly higher (96.4%, P =.011) for patients with t(8;21) and inv(16)/t(16;16) but significantly lower (74.5%, P =.022) for those with t(15;17). The 4-year survival rate for all patients was 43.5% +/- 2.4%; for those with an inv(16)/t(16;16), 75.0% +/- 8.6%; a normal karyotype, 53.8% +/- 4.9%; a t(8;21), 51.6% +/- 7.3%; a t(15;17), 39.8% +/- 6.9%; and an 11q23 abnormality, 32.9% +/- 5.1%. Four-year EFS estimates for patients with inv(16)/t(16;16) (58.2% +/- 10.9%, P =.007), t(8;21) (45.1% +/- 7.7%, P =.014), or normal karyotypes (43.1% +/- 5.0%, P =. 012) were higher than the 4-year EFS estimate for all patients, but EFS estimates for patients with t(15;17) (19.6% +/- 8.0%, P =.033) or 11q23 abnormalities (23.8% +/- 4.8%, P =.0013) were lower. EFS estimates did not differ significantly among 11q23 subgroups. Limited analysis suggested that patients with inv(16) can be salvaged better following relapse than those with t(8;21). Thus, patients with an inv(16)/t(16;16) may have high survival rates when treated with chemotherapy alone." @default.
• W200907363 created "2016-06-24" @default.
• W200907363 creator A5003743033 @default.
• W200907363 creator A5009716898 @default.
• W200907363 creator A5012609090 @default.
• W200907363 creator A5012776569 @default.
• W200907363 creator A5014628209 @default.
• W200907363 creator A5027364145 @default.
• W200907363 creator A5033105148 @default.
• W200907363 creator A5062366315 @default.
• W200907363 date "1999-12-01" @default.
• W200907363 modified "2023-09-27" @default.
• W200907363 title "Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821." @default.
• W200907363 cites W12190030 @default.
• W200907363 cites W1533510727 @default.
• W200907363 cites W1534965621 @default.
• W200907363 cites W1555238020 @default.
• W200907363 cites W1976439451 @default.
• W200907363 cites W1978762586 @default.
• W200907363 cites W1979300931 @default.
• W200907363 cites W1979835322 @default.
• W200907363 cites W1982078817 @default.
• W200907363 cites W2036280246 @default.
• W200907363 cites W2056968762 @default.
• W200907363 cites W2060201878 @default.
• W200907363 cites W2069428560 @default.
• W200907363 cites W2177773249 @default.
• W200907363 cites W2187668060 @default.
• W200907363 cites W2204038861 @default.
• W200907363 cites W2272418001 @default.
• W200907363 cites W2274220969 @default.
• W200907363 cites W2329489166 @default.
• W200907363 cites W2331485910 @default.
• W200907363 cites W2334200141 @default.
• W200907363 cites W2339359539 @default.
• W200907363 cites W2346419124 @default.
• W200907363 cites W2400109417 @default.
• W200907363 cites W2408785464 @default.
• W200907363 cites W2414294675 @default.
• W200907363 cites W2414522594 @default.
• W200907363 cites W2506529893 @default.
• W200907363 cites W274791679 @default.
• W200907363 cites W3041047318 @default.
• W200907363 cites W48493600 @default.
• W200907363 doi "https://doi.org/10.1182/blood.v94.11.3707" @default.
• W200907363 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10572083" @default.
• W200907363 hasPublicationYear "1999" @default.
• W200907363 type Work @default.
• W200907363 sameAs 200907363 @default.
• W200907363 citedByCount "108" @default.
• W200907363 countsByYear W2009073632012 @default.
• W200907363 countsByYear W2009073632013 @default.
• W200907363 countsByYear W2009073632014 @default.
• W200907363 countsByYear W2009073632015 @default.
• W200907363 countsByYear W2009073632016 @default.
• W200907363 countsByYear W2009073632017 @default.
• W200907363 countsByYear W2009073632018 @default.
• W200907363 countsByYear W2009073632019 @default.
• W200907363 countsByYear W2009073632022 @default.
• W200907363 countsByYear W2009073632023 @default.
• W200907363 crossrefType "journal-article" @default.
• W200907363 hasAuthorship W200907363A5003743033 @default.
• W200907363 hasAuthorship W200907363A5009716898 @default.
• W200907363 hasAuthorship W200907363A5012609090 @default.
• W200907363 hasAuthorship W200907363A5012776569 @default.
• W200907363 hasAuthorship W200907363A5014628209 @default.
• W200907363 hasAuthorship W200907363A5027364145 @default.
• W200907363 hasAuthorship W200907363A5033105148 @default.
• W200907363 hasAuthorship W200907363A5062366315 @default.
• W200907363 hasConcept C104317684 @default.
• W200907363 hasConcept C126322002 @default.
• W200907363 hasConcept C138626823 @default.
• W200907363 hasConcept C2776229224 @default.
• W200907363 hasConcept C2778461978 @default.
• W200907363 hasConcept C2778729363 @default.
• W200907363 hasConcept C2779142324 @default.
• W200907363 hasConcept C2779672484 @default.
• W200907363 hasConcept C2780189214 @default.
• W200907363 hasConcept C2780365373 @default.
• W200907363 hasConcept C30481170 @default.
• W200907363 hasConcept C53226629 @default.
• W200907363 hasConcept C54355233 @default.
• W200907363 hasConcept C71924100 @default.
• W200907363 hasConcept C86803240 @default.
• W200907363 hasConcept C90924648 @default.
• W200907363 hasConceptScore W200907363C104317684 @default.
• W200907363 hasConceptScore W200907363C126322002 @default.
• W200907363 hasConceptScore W200907363C138626823 @default.
• W200907363 hasConceptScore W200907363C2776229224 @default.
• W200907363 hasConceptScore W200907363C2778461978 @default.
• W200907363 hasConceptScore W200907363C2778729363 @default.
• W200907363 hasConceptScore W200907363C2779142324 @default.
• W200907363 hasConceptScore W200907363C2779672484 @default.
• W200907363 hasConceptScore W200907363C2780189214 @default.
• W200907363 hasConceptScore W200907363C2780365373 @default.
• W200907363 hasConceptScore W200907363C30481170 @default.
• W200907363 hasConceptScore W200907363C53226629 @default.
• W200907363 hasConceptScore W200907363C54355233 @default.

• next